GPI-3000
GPI-3000 is a NMDA receptor antagonist. GPI-3000 can ameliorate metabolic injury and shows neuroprotective effect. GPI-3000 can be used for the researches of metabolic and neurological disease[1].
Product Specifications
CAS Number
144301-37-1
UNSPSC
12352211
Target
IGluR
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
OC([C@H](N)C[C@@H]1[C@@H](CCCC1)CCP(O)(O)=O)=O
Molecular Formula
C11H22NO5P
Molecular Weight
279.27
References & Citations
[1]Davis S, et al. Parallel antioxidant and antiexcitotoxic therapy improves outcome after incomplete global cerebral ischemia in dogs. Stroke. 1997 Jan;28 (1) :198-204; discussion 204-5.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NMDA Receptor
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
167897 20 µg
KLK3, Recombinant, Human (Kallikrein-3, APS, KLK2A1, PSA, Hk3) discontinued
Sign In for Pricing
View Details 
MBS1188943-01 0.02 mg (E-Coli)
Recombinant Pelotomaculum thermopropionicum ATP synthase subunit beta (atpD)
Sign In for Pricing
View Details MBS1188943-02 0.02 mg (Yeast)
Recombinant Pelotomaculum thermopropionicum ATP synthase subunit beta (atpD)
Sign In for Pricing
View Details